Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001712661 | SCV000724346 | likely benign | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002232731 | SCV001004507 | benign | HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED | 2024-07-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002456372 | SCV002617085 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-04-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000863793 | SCV002083834 | likely benign | Classic homocystinuria | 2019-12-12 | no assertion criteria provided | clinical testing |